Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells

IL-17A is overexpressed in the lung during acute neutrophilic inflammation. Acetylcholine (ACh) increases IL-8 and Muc5AC production in airway epithelial cells. We aimed to characterize the involvement of nonneuronal components of cholinergic system on IL-8 and Muc5AC production in bronchial epithel...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Marina Montalbano, Giusy Daniela Albano, Anna Bonanno, Loredana Riccobono, Caterina Di Sano, Maria Ferraro, Liboria Siena, Giulia Anzalone, Rosalia Gagliardo, Michael Paul Pieper, Mark Gjomarkaj, Mirella Profita
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/9063842
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560593535500288
author Angela Marina Montalbano
Giusy Daniela Albano
Anna Bonanno
Loredana Riccobono
Caterina Di Sano
Maria Ferraro
Liboria Siena
Giulia Anzalone
Rosalia Gagliardo
Michael Paul Pieper
Mark Gjomarkaj
Mirella Profita
author_facet Angela Marina Montalbano
Giusy Daniela Albano
Anna Bonanno
Loredana Riccobono
Caterina Di Sano
Maria Ferraro
Liboria Siena
Giulia Anzalone
Rosalia Gagliardo
Michael Paul Pieper
Mark Gjomarkaj
Mirella Profita
author_sort Angela Marina Montalbano
collection DOAJ
description IL-17A is overexpressed in the lung during acute neutrophilic inflammation. Acetylcholine (ACh) increases IL-8 and Muc5AC production in airway epithelial cells. We aimed to characterize the involvement of nonneuronal components of cholinergic system on IL-8 and Muc5AC production in bronchial epithelial cells stimulated with IL-17A. Bronchial epithelial cells were stimulated with recombinant human IL-17A (rhIL-17A) to evaluate the ChAT expression, the ACh binding and production, the IL-8 release, and the Muc5AC production. Furthermore, the effectiveness of PD098,059 (inhibitor of MAPKK activation), Bay11-7082 (inhibitor of IkBα phosphorylation), Hemicholinium-3 (HCh-3) (choline uptake blocker), and Tiotropium bromide (Spiriva®) (anticholinergic drug) was tested in our in vitro model. We showed that rhIL-17A increased the expression of ChAT, the levels of ACh binding and production, and the IL-8 and Muc5AC production in stimulated bronchial epithelial cells compared with untreated cells. The pretreatment of the cells with PD098,059 and Bay11-7082 decreased the ChAT expression and the ACh production/binding, while HCh-3 and Tiotropium decreased the IL-8 and Muc5AC synthesis in bronchial epithelial cells stimulated with rhIL-17A. IL-17A is involved in the IL-8 and Muc5AC production promoting, via NFκB and ERK1/2 pathway activation, the synthesis of ChAT, and the related activity of autocrine ACh in bronchial epithelial cells.
format Article
id doaj-art-484f7845abd14b50bf92bdd9ee189963
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-484f7845abd14b50bf92bdd9ee1899632025-02-03T01:27:12ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/90638429063842Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial CellsAngela Marina Montalbano0Giusy Daniela Albano1Anna Bonanno2Loredana Riccobono3Caterina Di Sano4Maria Ferraro5Liboria Siena6Giulia Anzalone7Rosalia Gagliardo8Michael Paul Pieper9Mark Gjomarkaj10Mirella Profita11Institute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyBoehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, GermanyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyInstitute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM), National Research Council of Italy (CNR), 90146 Palermo, ItalyIL-17A is overexpressed in the lung during acute neutrophilic inflammation. Acetylcholine (ACh) increases IL-8 and Muc5AC production in airway epithelial cells. We aimed to characterize the involvement of nonneuronal components of cholinergic system on IL-8 and Muc5AC production in bronchial epithelial cells stimulated with IL-17A. Bronchial epithelial cells were stimulated with recombinant human IL-17A (rhIL-17A) to evaluate the ChAT expression, the ACh binding and production, the IL-8 release, and the Muc5AC production. Furthermore, the effectiveness of PD098,059 (inhibitor of MAPKK activation), Bay11-7082 (inhibitor of IkBα phosphorylation), Hemicholinium-3 (HCh-3) (choline uptake blocker), and Tiotropium bromide (Spiriva®) (anticholinergic drug) was tested in our in vitro model. We showed that rhIL-17A increased the expression of ChAT, the levels of ACh binding and production, and the IL-8 and Muc5AC production in stimulated bronchial epithelial cells compared with untreated cells. The pretreatment of the cells with PD098,059 and Bay11-7082 decreased the ChAT expression and the ACh production/binding, while HCh-3 and Tiotropium decreased the IL-8 and Muc5AC synthesis in bronchial epithelial cells stimulated with rhIL-17A. IL-17A is involved in the IL-8 and Muc5AC production promoting, via NFκB and ERK1/2 pathway activation, the synthesis of ChAT, and the related activity of autocrine ACh in bronchial epithelial cells.http://dx.doi.org/10.1155/2016/9063842
spellingShingle Angela Marina Montalbano
Giusy Daniela Albano
Anna Bonanno
Loredana Riccobono
Caterina Di Sano
Maria Ferraro
Liboria Siena
Giulia Anzalone
Rosalia Gagliardo
Michael Paul Pieper
Mark Gjomarkaj
Mirella Profita
Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
Mediators of Inflammation
title Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
title_full Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
title_fullStr Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
title_full_unstemmed Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
title_short Autocrine Acetylcholine, Induced by IL-17A via NFκB and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
title_sort autocrine acetylcholine induced by il 17a via nfκb and erk1 2 pathway activation promotes muc5ac and il 8 synthesis in bronchial epithelial cells
url http://dx.doi.org/10.1155/2016/9063842
work_keys_str_mv AT angelamarinamontalbano autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT giusydanielaalbano autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT annabonanno autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT loredanariccobono autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT caterinadisano autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT mariaferraro autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT liboriasiena autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT giuliaanzalone autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT rosaliagagliardo autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT michaelpaulpieper autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT markgjomarkaj autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells
AT mirellaprofita autocrineacetylcholineinducedbyil17avianfkbanderk12pathwayactivationpromotesmuc5acandil8synthesisinbronchialepithelialcells